The Fund Grade · free · no account needed
What grade does GABAX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Gabelli Asset Fund (The)
#485 of 500 graded active funds · blend · large segment peer group
The point · specialist footprint
GABAX puts less of its book behind proven specialists than 72% of graded funds.
Bottom 20%
● Bottom 40%
Middle
Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds with this little specialist backing trailed top-rung funds by about 3.8% per quarter and beat the S&P in only 22% of fund-quarters. If it also charges an active fee, the higher-graded alternatives deserve a look.
10,000+ funds tracked · the graded specialists among them drive every read
3 funds in the same segment carry an A. Members see the names and what they charge. See the alternatives →
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
GABAX vs the Honor Roll · share card ↗Conviction exposure
9.7%
of the book in specialist-converged names
Late-stage weight
19.8%
of the book in Crowded or Fading names
Active share
87%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
GABAX ranks 485 out of 500 graded funds, an F grade, with only 9.7% specialist backing and specialists actively leaving positions like CAT and FLS. There are higher graded funds in both this family and this segment. The one bright spot is early conviction in AME, BNY, and ITT, but that is a small offset against the broader picture.
→ Watch CAT and FLS closely, as specialists are fading from both and together they represent over 4% of the fund.
→ Compare GABAX against the three higher graded funds in this segment, where specialist backing is meaningfully stronger.
Support leaving these positions
Same family, higher grade
Read from today's disclosed book. Evidence, not advice.